Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1996 Jun;49(6):508–510. doi: 10.1136/jcp.49.6.508

Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease.

H Burgmann 1, U Hollenstein 1, T Maca 1, K Zedwitz-Liebenstein 1, F Thalhammer 1, R Koppensteiner 1, H Ehringer 1, W Graninger 1
PMCID: PMC500545  PMID: 8763269

Abstract

AIM: To measure serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease (PAOD) Fontaine stages IIb, III, and IV. METHODS: The study population comprised 38 patients (20 men and 18 women) with stage IV PAOD, 11 patients (six men and five women) with stage III PAOD, 18 patients (10 men and eight women) with stage IIb PAOD, and 23 patients (10 men and 13 women) with deep vein thrombosis. Fifteen normal subjects (matched for risk factors) and 10 patients (five men and five women) without PAOD served as controls. Serum samples were obtained at admission and serum laminin and angiogenin concentrations were measured using an enzyme linked immunosorbent assay. RESULTS: Patients with stage IV PAOD had higher serum laminin (mean +/- SEM; 826 +/- 97 ng/ml) and angiogenin concentrations (467 +/- 26 pg/ml) than normal subjects (laminin: 379 +/- 21 ng/ml; angiogenin: 358 +/- 16 pg/ml) and patients without PAOD (laminin: 277 +/- 34 ng/ml; angiogenin: 406 +/- 25 pg/ml). A significant correlation was found between angiogenin and laminin and between serum laminin and fibrinogen concentrations in patients with stage IV disease. CONCLUSIONS: Raised laminin and angiogenin concentrations may be indicators of endothelial damage caused by reduced vascular perfusion or compensatory revascularisation, or both.

Full text

PDF
508

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Badet J., Soncin F., N'Guyen T., Barritault D. In vivo and in vitro studies of angiogenin--a potent angiogenic factor. Blood Coagul Fibrinolysis. 1990 Dec;1(6):721–724. [PubMed] [Google Scholar]
  2. Bini A., Kudryk B. J. Fibrinogen and fibrin in the arterial wall. Thromb Res. 1994 Aug 1;75(3):337–341. doi: 10.1016/0049-3848(94)90247-x. [DOI] [PubMed] [Google Scholar]
  3. Ernst E. Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation. Eur Heart J. 1993 Dec;14 (Suppl K):82–87. [PubMed] [Google Scholar]
  4. Guseva N. G., Anikina N. V., Myllylä R., Risteli L., Risteli J., Chochlova J. V., Kivirikko K. I., Nassonova V. A. Markers of collagen and basement membrane metabolism in sera of patients with progressive systemic sclerosis. Ann Rheum Dis. 1991 Jul;50(7):481–486. doi: 10.1136/ard.50.7.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hasselbalch H., Junker P. Serum laminin P1 in idiopathic myelofibrosis and related diseases. Leuk Res. 1994 Aug;18(8):623–628. doi: 10.1016/0145-2126(94)90044-2. [DOI] [PubMed] [Google Scholar]
  6. Marx J. L. Angiogenesis research comes of age. Science. 1987 Jul 3;237(4810):23–24. doi: 10.1126/science.2440104. [DOI] [PubMed] [Google Scholar]
  7. Parise E. R., Leite-Mór M. M., Rosa H. Serum laminin in hepatosplenic human schistosomiasis. Mem Inst Oswaldo Cruz. 1992;87 (Suppl 4):127–128. doi: 10.1590/s0074-02761992000800018. [DOI] [PubMed] [Google Scholar]
  8. Pilgeram L. Atherogenesis and fibrinogen: historical perspective and current status. Naturwissenschaften. 1993 Dec;80(12):547–555. doi: 10.1007/BF01149268. [DOI] [PubMed] [Google Scholar]
  9. Ribatti D., Vacca A., Roncali L., Dammacco F. Angiogenesis under normal and pathological conditions. Haematologica. 1991 Jul-Aug;76(4):311–320. [PubMed] [Google Scholar]
  10. Risteli J., Draeger K. E., Regitz G., Neubauer H. P. Increase in circulating basement membrane antigens in diabetic rats and effects of insulin treatment. Diabetologia. 1982 Sep;23(3):266–269. doi: 10.1007/BF00252853. [DOI] [PubMed] [Google Scholar]
  11. Shapiro R., Strydom D. J., Olson K. A., Vallee B. L. Isolation of angiogenin from normal human plasma. Biochemistry. 1987 Aug 11;26(16):5141–5146. doi: 10.1021/bi00390a037. [DOI] [PubMed] [Google Scholar]
  12. Skalkidis Y., Katsouyanni K., Petridou E., Sehas M., Trichopoulos D. Risk factors of peripheral arterial occlusive disease: a case-control study in Greece. Int J Epidemiol. 1989 Sep;18(3):614–618. doi: 10.1093/ije/18.3.614. [DOI] [PubMed] [Google Scholar]
  13. Sosef M. N., Bosch J. G., van Oostayen J., Visser T., Reiber J. H., Rosendaal F. R. Relation of plasma coagulation factor VII and fibrinogen to carotid artery intima-media thickness. Thromb Haemost. 1994 Aug;72(2):250–254. [PubMed] [Google Scholar]
  14. Szirmai I. G., Kamondi A., Magyar H., Juhász C. Relation of laboratory and clinical variables to the grade of carotid atherosclerosis. Stroke. 1993 Dec;24(12):1811–1816. doi: 10.1161/01.str.24.12.1811. [DOI] [PubMed] [Google Scholar]
  15. Timpl R., Rohde H., Risteli L., Ott U., Robey P. G., Martin G. R. Laminin. Methods Enzymol. 1982;82(Pt A):831–838. doi: 10.1016/0076-6879(82)82104-6. [DOI] [PubMed] [Google Scholar]
  16. Timpl R., Rohde H., Robey P. G., Rennard S. I., Foidart J. M., Martin G. R. Laminin--a glycoprotein from basement membranes. J Biol Chem. 1979 Oct 10;254(19):9933–9937. [PubMed] [Google Scholar]
  17. Wenisch C., Graninger W., Viravan C., Looareesuwan S., Parschalk B., Wernsdorfer W. Serum laminin in malaria. J Clin Pathol. 1994 Sep;47(9):787–789. doi: 10.1136/jcp.47.9.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wenisch C., Myskiw D., Narzt E., Presterl E., Graninger W. Serum laminin in Graves' disease. Eur J Clin Invest. 1995 Jun;25(6):425–428. doi: 10.1111/j.1365-2362.1995.tb01724.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES